<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="033727-2018" EDITION="2018016"><TECHNICAL_SECTION><RECEPTION_ID>18-031819-001</RECEPTION_ID><DELETION_DATE>20180502</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>16</NO_OJ><DATE_PUB>20180124</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 016-033727</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:033727-2018:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL/><IA_URL_ETENDERING>http://madrid.org/contratospublicos</IA_URL_ETENDERING><ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV><ORIGINAL_CPV CODE="33652100">Antineoplastic agents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ES30">Comunidad de Madrid</n2016:PERFORMANCE_NUTS><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">1 059 491,77</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">0,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">55 189,20</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">318 747,50</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">0,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180122</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Фармацевтични продукти</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Léčivé přípravky a zdravotnické prostředky</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Lægemidler</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Arzneimittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Φαρμακευτικά προϊόντα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Pharmaceutical products</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Productos farmacéuticos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Ravimid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmaseuttiset tuotteet</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Produits pharmaceutiques</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Pharmaceutical products</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmaceutski proizvodi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Gyógyszerészeti termékek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Prodotti farmaceutici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmacijos produktai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmācijas izstrādājumi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Prodotti farmaċewtiċi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmaceutische producten</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Produkty farmaceutyczne</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Produtos farmacêuticos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Produse farmaceutice</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmaceutické výrobky</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Farmacevtski proizvodi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Móstoles</TI_TOWN><TI_TEXT>Läkemedel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Consejería de Sanidad de la Comunidad de Madrid — Servicio Madrileño de Salud — Hospital Universitario de Móstoles</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="ES" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Consejería de Sanidad de la Comunidad de Madrid — Servicio Madrileño de Salud — Hospital Universitario de Móstoles</OFFICIALNAME></ORGANISATION><ADDRESS>Río Júcar, s/n</ADDRESS><TOWN>Móstoles (Madrid)</TOWN><POSTAL_CODE>28935</POSTAL_CODE><COUNTRY VALUE="ES"/><CONTACT_POINT>Unidad de Contratación Administrativa del Hospital Universitario de Móstoles</CONTACT_POINT><ATTENTION>MANUEL TITOS MACHADO</ATTENTION><PHONE>+34 916648697</PHONE><E_MAILS><E_MAIL>contra.hmtl@salud.madrid.org</E_MAIL></E_MAILS><FAX>+34 916648784</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_BUYER>http://madrid.org/contratospublicos</URL_BUYER><URL_INFORMATION>http://madrid.org/contratospublicos</URL_INFORMATION></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="REGIONAL_AUTHORITY"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_YES><CONTACT_DATA_OTHER_BEHALF_CONTRACTING_AUTORITHY><ORGANISATION><OFFICIALNAME>Servicio Madrileño de Salud (SERMAS)</OFFICIALNAME></ORGANISATION><ADDRESS>Plaza de Carlos Trías Beltrán, 7</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28020</POSTAL_CODE><COUNTRY VALUE="ES"/></CONTACT_DATA_OTHER_BEHALF_CONTRACTING_AUTORITHY></PURCHASING_ON_BEHALF_YES></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Med. exclusivos: deferasirox, vinorelbina, trastuzumab y sapropterina</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/></TYPE_CONTRACT_LOCATION_W_PUB><LOCATION_NUTS><LOCATION><P>Almacén de Farmacia del Hospital de Móstoles.</P></LOCATION><n2016:NUTS CODE="ES30"/></LOCATION_NUTS><NOTICE_INVOLVES_DESC><CONCLUSION_FRAMEWORK_AGREEMENT/></NOTICE_INVOLVES_DESC><SHORT_CONTRACT_DESCRIPTION><P>Med. exclusivos: deferasirox, vinorelbina, trastuzumab y sapropterina.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33600000"/></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="33652100"/></CPV_ADDITIONAL></CPV><CONTRACT_COVERED_GPA VALUE="YES"/></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="1059491.77">1 059 491,77</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><F03_PT_NEGOTIATED_WITHOUT_COMPETITION><ANNEX_D><NO_MANUFACTURED_BY_DIRECTIVE/><JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASONS_PROVIDED_PARTICULAR_TENDERER><REASONS_PROVIDED_PARTICULAR_TENDERER_EXCLUSIVE_RIGHTS/></REASONS_PROVIDED_PARTICULAR_TENDERER><NO_EXTREME_URGENCY_EVENTS_UNFORESEEABLE/><NO_ADDITIONAL_WORKS/><NO_SUPPLIES_QUOTED_PURCHASED_COMMODITY_MARKET/></JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><NO_ONLY_IRREGULAR_INACCEPTABLE_TENDERERS/></ANNEX_D></F03_PT_NEGOTIATED_WITHOUT_COMPETITION></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL_F03><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL_F03><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>A/SUM-08900/2017</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><NO_PREVIOUS_PUBLICATION_EXISTS_F3/></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>A/SUM-08900/2017</CONTRACT_NUMBER><LOT_NUMBER>1</LOT_NUMBER><CONTRACT_TITLE><P>Nº orden 1: Deferasirox 90 mg comprimido; nº orden 2: Deferasirox 360 mg comprimido</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>14</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>0</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Resolución de declaración de desierto por renuncia</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Río Júcar, s/n</ADDRESS><TOWN>Móstoles</TOWN><POSTAL_CODE>28934</POSTAL_CODE><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="63805.03">63 805,03</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="0.00">0,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>1</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>A/SUM-008900/2017</CONTRACT_NUMBER><LOT_NUMBER>2</LOT_NUMBER><CONTRACT_TITLE><P>Nº orden 3: Vinorelbina 30 mg cáps.; nº orden 4: Vinorelbina 20 mg cápsula</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>14</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Pierre Fabre Ibérica, S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Ramón Trias Fargas, 7-11</ADDRESS><TOWN>Barcelona</TOWN><POSTAL_CODE>08005</POSTAL_CODE><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="118666.37">118 666,37</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="55189.20">55 189,20</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>1</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>A/SUM-008900/2017</CONTRACT_NUMBER><LOT_NUMBER>3</LOT_NUMBER><CONTRACT_TITLE><P>Trastuzumab 600 mg inyect. perf. 5 ml</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>14</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Roche Farma, S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Ribera del Loira, 50</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28042</POSTAL_CODE><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="685316.05">685 316,05</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="318747.50">318 747,50</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>1</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>A/SUM-008900/2017</CONTRACT_NUMBER><LOT_NUMBER>4</LOT_NUMBER><CONTRACT_TITLE><P>Sapropterina 100 mg comprimido</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>24</DAY><MONTH>10</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>0</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Realución de declaración de desierto, del Director Gerente del Hospital</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Río Júcar, s/n</ADDRESS><TOWN>Móstoles</TOWN><POSTAL_CODE>28934</POSTAL_CODE><COUNTRY VALUE="ES"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="191704.32">191 704,32</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="0.00">0,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_YEARS>1</NUMBER_OF_YEARS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><RELATES_TO_EU_PROJECT_NO/><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid</OFFICIALNAME></ORGANISATION><ADDRESS>Carrera de San Jerónimo, 13, 1ª planta.</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28013</POSTAL_CODE><COUNTRY VALUE="ES"/><E_MAILS><E_MAIL>tribunal.contratacion@madrid.org</E_MAIL></E_MAILS><PHONE>+34 917206346</PHONE></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE><LODGING_OF_APPEALS><LODGING_OF_APPEALS_PRECISION><P>Contra el presente acto, que pone fin a la vía administrativa, podrá interponerse con carácter potestativo recurso especial en materia de contratación, anunciándolo previamente al órgano de contratación, en el plazo de quince días hábiles contados desde el día siguiente a aquel en que se remita la notificación, ante el mismo órgano que lo ha dictado o ante el Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid, o bien, directamente, recurso contencioso-administrativo en el plazo de dos meses contados desde el día siguiente al de la recepción de la notificación, ante los Juzgados de lo Contencioso-Administrativo de Madrid, sin perjuicio de cualquier otro recurso que se estime procedente interponer todo ello conforme a lo dispuesto en los artículos 40 y siguientes del RDL 3/2011, de 14 de noviembre, por el que se aprueba el Texto Refundido de la Ley de Contratos del Sector Público; artículos 123 y 124 de la Ley 39/2015, de 1 de octubre, del Procedimiento Administrativo Común de las Administraciones Públicas; y artículos 8 al 12 de la Ley 29/1988, de 13 de julio, reguladora de la Jurisdicción Contencioso-Administrativa.</P></LODGING_OF_APPEALS_PRECISION></LODGING_OF_APPEALS><LODGING_INFORMATION_FOR_SERVICE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Servicio Jurídico del Hospital Universitario de Móstoles</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Río Júcar, s/n</ADDRESS><TOWN>Móstoles</TOWN><POSTAL_CODE>28935</POSTAL_CODE><COUNTRY VALUE="ES"/><E_MAILS><E_MAIL>nuria.ricord@salud.madrid.org</E_MAIL></E_MAILS><PHONE>+34 916648767</PHONE></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></LODGING_INFORMATION_FOR_SERVICE></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>22</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>